<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390607</url>
  </required_header>
  <id_info>
    <org_study_id>2020Cleu</org_study_id>
    <nct_id>NCT04390607</nct_id>
  </id_info>
  <brief_title>Leukocyte Esterase Sensor Test</brief_title>
  <official_title>A Research Study to Determine if a Leukocyte Esterase Electrochemical Assay Can be Used as a Marker for Periprosthetic Joint Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to assess the diagnostic efficacy of the quantitative
      electrochemical LE biosensor for periprosthetic joint infection (PJI). The secondary
      objective of this study is to assess the utility of d-lactase as adjunct biomarker to LE in
      making a diagnosis of PJI.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Receiver Operating Curve (ROC) analysis</measure>
    <time_frame>20 minutes</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">230</enrollment>
  <condition>Prosthetic Joint Infection</condition>
  <arm_group>
    <arm_group_label>Subjects undergoing revision joint surgery</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>leukocyte esterase electrochemical assay</intervention_name>
    <description>A sample of blood drawn for routine standard of care laboratory assessments will be used to also test the new electrochemical assay. This is a validation study and the results of the electrochemical assay will not be used to treat patients</description>
    <arm_group_label>Subjects undergoing revision joint surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This will be a prospective study with consecutive revision joint surgery patients
        determined to be in one of three groups: 1) patients undergoing revision joint replacement
        for presumed aseptic loosening, 2) patients undergoing irrigation and debridement with
        implant retention, and 3) patients undergoing two stage revision for infection. We will
        also recruit a small number of patients undergoing primary joint replacement (Jefferson
        hospital only).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1: consecutive patients undergoing at least one of the following procedures: presumed
        aseptic revision arthroplasty, irrigation and debridement, radical resection for
        periprosthetic joint infection

        Exclusion Criteria:

          1. known active gout flare

          2. existing corrosion or metallosis

          3. inflammatory arthritis

          4. preexisting diagnosis of infection in the same joint

          5. patients undergoing second-stage procedure for infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniel Waren, MSPH</last_name>
      <phone>954-559-2251</phone>
      <email>daniel.waren@nyulangone.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 11, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

